Skip to main content
Sunday
July 03, 2022
Sign In
Subscribe
Home
Economy
Stocks
Analysis
World+Biz
Sports
Features
Epaper
More
Subscribe
COVID-19
Bangladesh
Splash
Videos
Games
Long Read
Infograph
Interviews
Offbeat
Thoughts
Podcast
Quiz
Tech
Archive
Trial By Trivia
Magazine
Supplement
বাংলা
SUNDAY,
JULY 03, 2022
Bharat Biotech
Coronavirus chronicle
Indian drug regulator okays Covaxin for 6-12 year olds, Corbevax for 5-12 bracket
Coronavirus chronicle
India gives nod to Bharat Biotech for intranasal Covid booster doses
Coronavirus chronicle
India's Bharat Biotech says Covaxin booster shot neutralises Omicron
Coronavirus chronicle
Bharat Biotech gets approval to test nasal Covid-19 shot as booster - report
Coronavirus chronicle
Bharat Biotech to produce 1 billion nasal vaccines in 2022
Coronavirus chronicle
Bharat's Covid-19 shot 50% effective at height of India infections - small study
Coronavirus chronicle
India recommends homemade Covid-19 vaccine for kids aged 2 and above
World+Biz
Bharat Biotech says it received no advance payment from Brazil govt for Covaxin
Coronavirus chronicle
Covaxin manufacturing to vaccination takes 4 months, says Bharat Biotech
Coronavirus chronicle
Bharat Biotech submits ‘90% of documents’ for WHO nod
Coronavirus chronicle
India's Bharat Biotech to produce additional 200 mln Covid-19 vaccine doses per year
Coronavirus chronicle
50 employees suffering from Covid: Bharat Biotech's message amid vaccine woes
Coronavirus chronicle
Indian govt tells Serum Institute, Bharat biotech to lower their Covid vaccine prices
Show More